Owens & Minor, Inc.(OMI)

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

Snapshot
$2.80
52-Week Range
$2.38 – $9.55
YTD
+0.00%
IV Rank (30D)
47.04
Straddle Price
$0.68
P/C Vol Ratio
0.83
Market Cap
$0.2B
Fair Value

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 0.5% and dividend payments are stable.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.00%
Beta vs SPY1.00
Cost of Equity (CAPM)9.50% (VRP-adj)
WACC4.90%
Volatility Risk Premium+188.0pp (IV − HV30), ERP adj +50bps
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)+5.2%
DCF Horizon5 years explicit + fade
Forward Tilt (NTM/TTM)×1.05 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$-0.3B
Book / Price-213.4%
Gross Margin (TTM)46.7%
FCF Margin (TTM)-12.3%
Quality Score0/6 — cyclical/struggling (5y DCF)
SMA 50$2.83 (Market Anchor value)
SMA 20 / Bollinger Mid$2.81
Bollinger Width / SMA20583.2% (drives anchor stability)
Net Debt$1.5B
Market Cap$0B
Blended Fair Value
Current Price
$2.80
Deviation
MethodImplied PriceWeightDetail
DCF n/a 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0%
Peer EV/EBITDA n/a 0%
Peer P/B n/a 0%
Peer P/S n/a 0%
Market Anchor (SMA50) $2.83 0% stability 0% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-06-01 · updated 2026-06-01 09:30:57.893000
Info
Industry (SIC)
WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES (5047)
Exchange
XNYS
Market Cap
$0.2B

Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the…

Price History
Seasonality
MonthAvg ReturnYears of Data
Jan +4.02% 22
Feb +0.03% 22
Mar +0.91% 23
Apr -3.40% 22
May +0.31% 22
Jun +1.96% 22
Jul +5.21% 22
Aug -1.20% 22
Sep +1.69% 22
Oct -5.30% 22
Nov +0.98% 22
Dec -1.57% 22
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators
SMA 20: $2.81
SMA 50: $2.83
SMA 200: $5.60
Current: $2.80
EMA 12: $2.80
EMA 26: $2.85
MACD: -0.0458 | Signal: 0.0201
BEARISH
ADX (14): 16.30
RANGE
+DI: 21.58
−DI: 26.43
Momentum Oscillators
RSI (14): 44.85
NEUTRAL
Stoch %K: 90.25
Stoch %D: 77.01
Williams %R: -12.06
Volume & Volatility
BB Upper: $3.04
BB Lower: $2.58
NEUTRAL
OBV: -74,164,269
Vol SMA 20: 982,540
Vol ROC: -100.00%
ATR: $0.09
True Range: $0.00
HV 20: 44.9%
HV 30: 54.6%
HV 60: 75.4%

Data Summary
Data Points: 500
Last Updated: 2026-06-12T21:15:21.847000
Date Range: 2024-01-19T00:00:00 – 2026-03-16T00:00:00
AI Analysis

Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

News
Earnings History
5 of 6 under expected move
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2024-08-02 Pre-Market 15.44% 4.71% 0.31x Within
2024-11-04 Pre-Market 21.09% 0.93% 0.04x Within
2025-02-03 After-Close 21.50% 3.44% 0.16x Within
2025-05-08 Pre-Market 18.42% 9.95% 0.54x Within
2025-08-11 Pre-Market 24.68% 35.40% 1.43x Exceeded
2025-10-30 After-Close 18.65% 17.34% 0.93x Within
Options Activity
IV Rank (30D)
47.04
IV Rank (7D)
47.04
Avg IV
594.3%
Straddle (30D)
$0.68
Straddle (7D)
$0.68
P/C Volume
0.83
Spread Scanner GPU

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Volatility Surface

Enter a ticker to render the implied volatility surface.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
1.14
Correlation (SPY)
15.4%
0.02
Ann. Volatility
82.1%
SPY Volatility
11.1%

Above average volatility - stock moves with market amplification

Beta & Alpha Over Time
Institutional Ownership (13F)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

# Filer Shares Value % of Total % of Float Period
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period
Insider Activity
Latest: 2025-11-20
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2025-11-20 Andrew G Long EVP, CEO P&HS Gift (G) −47,908 EDGAR
2025-09-24 Jonathan A Leon EVP & CFO Tax (F) −4,265 $5.40 -$23.0K EDGAR
2025-08-14 Coliseum Capital Management, LLC 10%+ Owner Buy (P) +7,689,260 $5.27 $40.50M EDGAR
2025-06-04 Jennifer A Stone EVP, CHRO Tax (F) −5,764 $6.35 -$36.6K EDGAR
2025-05-20 Heath H Galloway EVP,General Counsel & CorpSecy Tax (F) −1,768 $7.38 -$13.0K EDGAR
2025-05-16 Michael Wayne Lowry SVP, Corporate Controller Tax (F) −1,533 $7.00 -$10.7K EDGAR
2025-05-16 Rita Johnson-Mills Director Award (A) +28,914 EDGAR
2025-05-16 Andrew G Long EVP, CEO P&HS Tax (F) −19,081 $7.00 -$133.6K EDGAR
2025-05-16 Teresa L. Kline Director Award (A) +28,914 EDGAR
2025-05-16 Perry A Bernocchi EVP, CEO,. Patient Direct Tax (F) −13,394 $7.00 -$93.8K EDGAR
2025-05-16 Carissa Rollins Director Award (A) +28,914 EDGAR
2025-05-16 Kenneth Gardner-Smith Director Award (A) +28,914 EDGAR
2025-05-16 Edward A Pesicka President & CEO Tax (F) −35,208 $7.00 -$246.5K EDGAR
2025-05-16 Gwendolyn M Bingham Director Grant (A) +28,914 RSU EDGAR
2025-05-16 Jonathan A Leon EVP & CFO Tax (F) −2,641 $7.00 -$18.5K EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
Insider Holdings
71 insiders · @ $2.80
Officers, directors, and 10%+ owners ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Coliseum Capital Management, LLC 10%+ Owner 12,282,955 $34.41M $55.87M 2 2025-08-14
2 COLISEUM CAPITAL PARTNERS, L.P. 10%+ Owner 10,784,599 $30.21M $21.46M 1 2025-04-07
3 Christopher S Shackelton 10%+ Owner 9,824,599 $27.52M $136.93M 1 2025-03-04
4 Edward A Pesicka President & CEO 1,149,422 $3.22M -$26.09M 33 2025-05-16
5 Andrew G Long EVP, CEO P&HS 448,425 $1.26M -$944.6K 25 2025-11-20
6 PAUL CODY PHIPPS President & CEO 383,229 $1.07M $0 9 2018-07-03
7 Nicholas J Pace EVP, General Counsel 267,095 $748.2K -$3.36M 26 2023-05-17
8 Perry A Bernocchi EVP, CEO,. Patient Direct 233,966 $655.4K -$1.30M 14 2025-05-16
9 Christopher M Lowery Former Pres, Global Products 232,120 $650.2K -$5.06M 20 2022-04-04
10 Jonathan A Leon EVP & CFO 218,522 $612.1K -$2.35M 53 2025-09-24
11 Jeffrey T Jochims EVP, COO and 203,956 $571.3K -$1.50M 14 2022-07-05
12 Shana Carol Neal Chief Human Resources Officer 158,594 $444.3K -$1.64M 15 2022-03-07
13 RICHARD A MEIER EVP, Chief Financial Officer 127,158 $356.2K $87.1K 13 2018-02-12
14 Stuart Raymond Morris-Hipkins President 123,864 $347.0K $0 5 2019-03-14
15 ROBERT C SLEDD Director 121,990 $341.7K $861.7K 19 2021-03-02
16 Michael Wayne Lowry SVP, Corporate Controller 121,921 $341.5K -$2.70M 71 2025-05-16
17 Heath H Galloway EVP,General Counsel & CorpSecy 117,044 $327.9K -$178.7K 12 2025-05-20
18 Robert K Snead EVP, CFO 115,794 $324.4K $0 6 2019-05-20
19 Joseph S Pekala SVP, Chief Information Officer 113,244 $317.2K $0 3 2019-12-11
20 Jennifer A Stone EVP, CHRO 110,327 $309.1K $0 3 2025-06-04
21 Snehashish Sarkar EVP, Chief Information Officer 108,586 $304.2K -$198.0K 13 2025-05-16
22 Daniel J Starck EVP, Business Excellence 95,612 $267.8K $0 5 2024-05-16
23 JAMES L BIERMAN President & CEO 93,277 $261.3K -$396.8K 24 2015-03-10
24 ANNE M WHITTEMORE Director 84,839 $237.7K -$1.98M 80 2020-01-02
25 Robert J Henkel Director 77,412 $216.9K $523.3K 36 2025-05-16
26 JAMES E UKROP Director 74,610 $209.0K $0 8 2011-02-28
27 Mark P Zacur EVP, Chief Commercial Officer 71,769 $201.0K -$1.34M 5 2021-06-07
28 ERIKA T DAVIS SVP, Chief Administr. Officer 71,610 $200.6K -$5.07M 58 2019-03-06
29 JOHN T CROTTY Director 63,037 $176.6K $0 6 2010-11-24
30 EDDIE N JR MOORE Director 61,893 $173.4K -$1.10M 90 2021-04-02
31 Stephen W Klemash Director 59,051 $165.4K $0 6 2025-05-16
32 JAMES E ROGERS Director 58,991 $165.3K -$991.6K 24 2017-06-21
33 GRACE R DENTTARTOG SVP, General Counsel 55,724 $156.1K -$2.92M 44 2016-02-09
34 Kenneth Gardner-Smith Director 54,922 $153.9K $0 5 2025-05-16
35 Rita Johnson-Mills Director 54,125 $151.6K $0 4 2025-05-16
36 Teresa L. Kline Director 54,125 $151.6K $0 4 2025-05-16
37 Carissa Rollins Director 53,902 $151.0K $0 4 2025-05-16
38 EV III Clarke Exec. VP, Supply Chain 50,761 $142.2K -$762.1K 11 2011-04-29
39 Alexander J Bruni EVP, CFO 49,950 $139.9K -$410.3K 8 2024-06-04
40 Michael C Riordan Director 48,707 $136.4K $273.4K 4 2021-05-03
41 Rony Camil Kordahi EVP, North American Operations 47,185 $132.2K -$71.6K 7 2018-04-05
42 Tammy L Gomez EVP, CHRO 46,782 $131.1K $0 3 2023-08-16
43 BARBARA B HILL Director 46,738 $130.9K $0 30 2019-07-02
44 A MARSHALL ACUFF Director 46,101 $129.1K $0 14 2013-02-15
45 CHARLES C COLPO SVP, Strategic Supplier Mgmt 45,872 $128.5K -$6.33M 65 2019-03-06
46 Timothy P Connolly EVP, Operations & Supply Chain 42,808 $119.9K $0 1 2018-06-26
47 Geoff Taylor Marlatt SVP, Manufacturer Services 42,607 $119.4K -$317.6K 19 2019-03-06
48 OLWEN B CAPE Vice President, Controller 40,717 $114.1K -$855.0K 18 2010-04-28
49 Mark A Beck Director 40,068 $112.2K -$161.2K 15 2025-05-16
50 Richard W Mears SVP, Chief Information Officer 35,664 $99.9K -$1.35M 33 2016-10-04
51 JOHN W GERDELMAN Director 35,635 $99.8K $0 13 2018-10-02
52 Daniel Todd Healy SVP, Provider Services 33,674 $94.3K $0 5 2015-04-28
53 G GILMER III MINOR Director 29,350 $82.2K -$11.38M 30 2013-02-27
54 STUART ESSIG Director 27,585 $77.3K $500.0K 20 2019-07-02
55 Martha H. Marsh Director 26,420 $74.0K $0 6 2018-05-18
56 PETER S REDDING Director 25,713 $72.0K -$864.1K 59 2012-04-02
57 MARK A VAN SUMEREN SVP, Strategy & Business Devel 25,398 $71.1K -$2.54M 36 2014-02-10
58 Gwendolyn M Bingham Director 22,184 $62.1K -$268.4K 8 2025-05-16
59 Stephen Russell Olive SVP, Chief Information Officer 20,607 $57.7K $0 3 2018-02-12
60 Brian J Shotto SVP, Manufacturer Services 19,416 $54.4K $0 5 2014-02-11
61 JEFFREY KACZKA SVP, Chief Financial Officer 18,801 $52.7K $0 1 2007-02-05
62 Michael Jay Romans SVP, Human Resources 14,698 $41.2K $0 4 2017-03-01
63 Scott W Perkins VP, West 14,505 $40.6K -$589.0K 12 2009-02-05
64 William Marshall Simpson EVP, Chief Commercial Officer 14,204 $39.8K -$1.95M 22 2016-02-09
65 RICHARD F BOZARD Vice President, Treasurer 12,606 $35.3K -$889.8K 13 2009-02-05
66 CRAIG R SMITH Director 10,758 $30.1K -$31.15M 83 2017-05-03
67 DAVID S SIMMONS Director 10,721 $30.0K $72.0K 11 2018-04-02
68 Lemuel E Lewis Director 10,355 $29.0K $0 99 2019-04-02
69 D ANDREW EDWARDS VP, Controller & 7,732 $21.7K $0 7 2013-02-06
70 RICHARD E FOGG Director 5,516 $15.5K -$1.28M 74 2014-01-02
71 Aster Angagaw Director 4,708 $13.2K $0 2 2021-05-03
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

TTM Revenue$2.8B
TTM Net Income$-1.1B
TTM EPS$-14.32